O slideshow foi denunciado.
Utilizamos seu perfil e dados de atividades no LinkedIn para personalizar e exibir anúncios mais relevantes. Altere suas preferências de anúncios quando desejar.

Roadshow:Health & Life Science

220 visualizações

Publicada em

4th edition of Upcycle your business transformation:

Publicada em: Tecnologia
  • Paid To Write? Earn up to $200/day on with simple writing jobs. ■■■ http://t.cn/AieXS5j0
       Responder 
    Tem certeza que deseja  Sim  Não
    Insira sua mensagem aqui

Roadshow:Health & Life Science

  1. 1. 1. Vrijdag 16/06/2017: focus Energie 2. Vrijdag 29/09/2017: focus Chemie 3. Vrijdag 01/12/2017: focus Materialen 4. Vrijdag 02/02/2018: focus Healthcare & life Science 5. Vrijdag 20/04/2018 : focus Smart Human Capital Upcycle your Business Transformation
  2. 2. 14% 11% 12% 10% 10% 9% 9% 7% 5% 4% 3% 3% 2% 1% Assignments per sector 2007 - 2017 Production food FMCG Production Non Food Services Pharma & Healthcare Construction ICT Transport & Logistics Bank & Insurances Energy Automotive Chemistry Government Aviation & Aerospace
  3. 3. We are XPErts by nature Farmareus Pfizer stopt onderzoek naar alzheimer- en parkinsonmedicijnen Na een reorganisatie bij Pfizer stopt het bedrijf de zoektocht naar nieuwe medicijnen voor de behandeling van alzheimer en parkinson. Dat heeft Pfizer zelf bekendgemaakt. Het vrijgekomen budget zal volgens het bedrijf in ander onderzoek geïnvesteerd worden.
  4. 4. Help our life-science partners, improve quality of life by providing the expertise they require to develop the drugs, products and support their customers and patients need. OUR MISSION
  5. 5. XPE Pharma & Science Belgian Footprint 300 XPErts + 30 nationalities Clients in Pharma, Biotech, Medical Devices, Diagnostics, Laboratories, Food and Beverage, Veterinary, Healthcare environment Offices in Wavre & Brussels Global Competence Center in Cluj (Romania) 0 50 100 150 200 250 300 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 Number of consultants Launch
  6. 6. Fields of XPErtise combined with our Services STAFFING & CONSULTANCY PROJECT MANAGEMENT & DELIVERY Technical Clinical Medical EXPERT SOURCING OUTSOURCING SERVICES Sales & Marketing PERMANENT PLACEMENT
  7. 7. XPE experts XPE expertise Discovery phase Preclinical research Research director Clinical studies Study manager, CRA, Data manager, Statistician, Medical writer, Project nurses Scientific writing, publications, eTMF management Submission and approval Regulatory affairs Manager, publishers RA writing Pricing and reimburse- ment Market access manager Observational studies Manu- facturing Validation, engineer, QA Officer, Lab technician, Supply chain manager QA system management Go to market Sales rep, Marketing manager, Medical science liaison Salesforce outsourcing, After sales/ Healthcare Nurses, Elderly care Patient support solutions Experts & expertise for each phase in the lifecycle of a drug or medical device TRANSVERSAL: TRAINING, QUALITY MANAGEMENT, IM & IT, TRAINING SOLUTIONS
  8. 8. Adherence to treatment guidelines for ovarian cancer is correlated with improved survival rates. XPE provides psychological and adherence training at a patient’s home. OVARIAN CANCER
  9. 9. About 1.7 to 5 billion cases of diarrhea occur per year. It is the second most common cause of death in children younger than 5. XPE participated developing a vaccine to prevent Rotavirus: • developing clinical studies protocol, • writing articles for healthcare professionals, • creating presentation materials for congresses. DIARRHEA
  10. 10. The average fatality rate of Ebola virus is around 50%. Case fatality rates have varied from 25% to 90% in past outbreaks. XPE participated in the development of a vaccine by writing protocols for the clinical study EBOLA VIRUS
  11. 11. Transformation
  12. 12. Develop & renew expertise Transformation • From experts to expertise • From staffing provider to consultancy and project management leader • Talent leadership • From recruiter to digital marketeer
  13. 13. Technology Transformation/Innovation •E-platforms •Videos in publication management •Digital follow up of PSP •Innovation manager •Joined projects with Modis IT & Engineering
  14. 14. Data Protection Transformation • Cybersecurity • GDPR • Compliance .
  15. 15. VISION ON TECHNOLOGY FOR A BETTER WORLD SUSTAINABLE SOCIETY
  16. 16. WE CREATE VALUE BY IMPACT SUSTAINABLE GROWTH IS THE ONLY POSSIBLE GROWTH DIRECT IMPACT INDIRECT IMPACT SYSTEM/FRAME CHANGE
  17. 17. VITO CONVERTS IDEAS INTO REALITY VITO MAKES OUR ENVIRONMENT HEALTHY AND SUSTAINABLE FROM SCIENCE TO APPLICATION VITO SUPPORTS THESE SUSTAINABLE DEVELOPMENT GOALS
  18. 18. WE DE-RISK INNOVATION FOR COMPANIES WE CONNECT RESEARCH AND MARKET, KNOWLEDGE AND BUSINESS WE OFFER SOLUTIONS WORLDWIDE
  19. 19. WE MAKE FLANDERS AND THE WORLD MORE SUSTAINABLE HEALTH MATERIALS ENERGY CHEMISTRY LAND USE
  20. 20. FLEXIBLE ENERGY SYSTEMS THE ENERGY LAB OF THE FUTURE
  21. 21. ALTERNATIVES FOR LIMITED RESOURCES AND POLLUTING PROCESSES EFFICIENT SUSTAINABLE CHEMISTRY
  22. 22. TRANSITION TO A CIRCULAR ECONOMY MATERIALS CIRCULAR
  23. 23. MITIGATE HEALTH SYSTEMS PREVENTIVE HEALTH CARE
  24. 24. INSIGHT IN OUR EARTH BETTER MANAGING RESOURCES THANKS TO ADVANCED ENVIRONMENTAL MONITORING LAND - WATER - AIR
  25. 25. WE PROVIDE SOLUTIONS WORLDWIDE 227 SCIENTIFIC PUBLICATIONS34 NATIONALITIES MORE THAN 400 PATENTS 24 NEW PATENTS EVERY YEAR > €170 MILLION TURNOVER 784 EMPLOYEES 76 SME’S 91 PHD’S AND POSTDOCS Experts Projects Experts and Projects SUSTAINABLE ENTREPRENEURAL INSPIRING CREATIVE
  26. 26. VITO PILLARS FOR VALORISATION
  27. 27. VITO TECH TRANSFER WHAT CAN WE DO FOR YOU? ©VITO – Not for distribution 6/02/2018
  28. 28. The VITO Tech Transfer Office builds cleantech ventures and transfers technology for a more sustainable, circular economy. We connect VITO & aspiring entrepreneurs to start & grow businesses, that address the societal challenges of tomorrow. Our quest is to identify, nurture, guide & close opportunities with capacity to profitable growth & worldwide impact. TECH TRANSFER TEAM – MISSION
  29. 29. PARTNERS IN THE TECH TRANSFER PROCESS 6/02/2018 ©VITO – Not for distribution 40
  30. 30. PORTFOLIO 6/02/2018 ©VITO – Not for distribution 42
  31. 31. VENTURES (*) pipeline <2014 2014 2015 2016 20174 1 2 *
  32. 32. VITO SPIN-OFFS & STARTUP LICENCES OVERVIEW CO2-negative building materials Sustainable thermal energy systems Privacy-compliant patient monitoring 3D coating with hard materials Drone flight control platform SW Battery data management SW Atmospheric plasma devices Virtual cycling platform for homebound elderly 3D backflush membranes Soil pollutant Monitoring & modelling In 3D & over time 20172014 VITOFOAMPortal for mapping air pollutant exposure Retina (eye) health monitoring (pollution & dementia) Titanium foam for implants (partner in China) Drone flight Platform SW
  33. 33. International research & technology centre Cleantech & sustainable innovation Connecting partners & stakeholders Bridging knowlegde, policy & business Active Technology Transfer Office & Team VITO – VISION ON TECHNOLOGY ENERGY MATERIALS CHEMISTRY HEALTH LAND USE
  34. 34. Thank you
  35. 35. A new vision on Oxygen Therapy for Hospitals Keynote – Health & Life Science 02/02/2018 www.oxypoint.eu
  36. 36. First Oxypoint Commercial Innovation The Econo-Comfort O2-Flowmeter “More Comfort with less O2 spilling!” 6/02/2018 Oxypoint – confidential – Patent protected 51
  37. 37. Econo-Comfort O2-Flowmeter = Pneumatic device Combines 2 modes: • Comfort mode (unique for hospitals) • Continuous mode (standard in hospitals) • USP: • More comfort for the patient • Less consumption (up to 75% less O2) • ROI for the hospital: 3 to 4 years 6/02/2018 52Oxypoint – confidential – Patent protected
  38. 38. O2 delivery in comfort mode 6/02/2018 53 Breathing pattern Inspiration Expiration Classic Continuous O2 Comfort O2 Oxypoint – confidential – Patent protected Comfort O2
  39. 39. “More Comfort” 6/02/2018 54Oxypoint – confidential – Patent protected
  40. 40. 55 Patented technology Measuring relative humidity = “Comfort measurement” 6/02/2018 55 Oxypoint – confidential – Patent protected
  41. 41. Continu 5 Comfort 5Comfort 4Comfort 3Comfort 2Comfort 1 Continu 4 Continu 3 Continu 2 Continu 1 Blanco Relative humidity in the nose with O2 6/02/2018 56Oxypoint – confidential – Patent protected
  42. 42. 6/02/2018 57 No more humidifiers => lower infection risk! Oxypoint – confidential – Patent protected
  43. 43. “Less Spilling” 6/02/2018 Oxypoint – confidential – Patent protected 58
  44. 44. University Hospital of Antwerp Cardiac Surgery ‘Low Care’ (26 beds) 6/02/2018 59Oxypoint – confidential – Patent protected
  45. 45. University Hospital of Antwerp Cardiac Surgery ‘Low Care’ (26 beds) 6/02/2018 60 « Reduced oxygen spilling of ± 75% (mixed use) » « Equal patient oxygenation confirmed (SaO2) » Oxypoint – confidential – Patent protected
  46. 46. University Hospital of Ghent Respiratory Care (30 beds) 6/02/2018 61Oxypoint – confidential – Patent protected
  47. 47. University Hospital of Ghent Respiratory Care (30 beds) 6/02/2018 62 « Reduced oxygen spilling of ± 40% (mixed use) » « Equal patient oxygenation confirmed (SaO2) » Oxypoint – confidential – Patent protected
  48. 48. Valve closes automatically => No more open flowmeters 6/02/2018 63Oxypoint – confidential – Patent protected
  49. 49. Next generation Hospital Oxygen devices 6/02/2018 64Oxypoint – confidential – Patent protected
  50. 50. Connected Hospital Oxygen therapy Oxypoint – confidential – Patent protected6/02/2018 65
  51. 51. Connected Hospital Oxygen therapy Oxypoint – confidential – Patent protected6/02/2018 66
  52. 52. Mobile Hospital Oxygen therapy Oxypoint – confidential – Patent protected6/02/2018 67
  53. 53. Mobile Hospital Oxygen therapy Oxypoint – confidential – Patent protected6/02/2018 68
  54. 54. Ready to grow 6/02/2018 69Oxypoint – confidential – Patent protected
  55. 55. 2011 2012 2013 2014 2015 2016 2017 Milestone Company creation Milestone Company People Product Commercial Milestone Manufacturer selection Milestone CE Mark Milestone Proof of Concept Patent Application (awarded) Milestone First customer Milestone 5 customer references Milestone 10 customer references Milestone First export Milestone 20 customer references Milestone Growth preparation VC contacts. Milestones “Most promising starter” nomination Trends Gazellen 2014 Milestones Trends Gazellen 2015 Milestone Medica International interest COMMERCIAL VALIDATION EXPANSION Company Milestones Oxypoint – confidential – Patent protected6/02/2018 70 Milestones Team grows: 5FTE Milestone Sold 2000 products Milestones Team starts: 2 FTE
  56. 56. Fast growing and strong track record of 20 hospitals Oxypoint – confidential – Patent protected6/02/2018 71
  57. 57. Innovation prices and awards
  58. 58. Conclusion Health & Life Science Highly regulated field and hospitals are slow adopters Innovation Promising future pipeline and interesting new tech. ecosystem Governmental help Very helpful innovation and growth subsidies Idea: creating incentives for (hospital) clients to buy innovations Employment Phase 1 (past, self-sufficient small team) 2 FTE => 5 FTE Phase 2 (future, post Series A Financing) 5 FTE => 10 FTE => 16 FTE 6/02/2018 73Oxypoint – confidential – Patent protected
  59. 59. SMART & HEALTHY CITIES - THE ENERGY PERSPECTIVE February 2018 6/02/2018 ©VITO – Not for distribution 75
  60. 60. Urbanisation challenge 6/02/2018 ©VITO – Not for distribution 76 Cities take 2%of global surface
  61. 61. • Energyville is a top research institute on sustainable energy system for large urban areas. Energyville’s 300 researchers develop new technology, knowledge and methodologies, resulting in new products and services, development of human capital, and science-based policy support from local to global level.
  62. 62. 6/02/2018 ©VITO – Not for distribution 78 THE URBAN COMPLEXITY REQUIRES CREATIVITY, INNOVATION, INTEGRATION
  63. 63. 6/02/2018 ©VITO – Not for distribution 79 TO MAKE OUR CITIES A HEALTHY, CLEAN AND PRODUCTIVE ENVIRONMENT
  64. 64. NOVEL APPROACH TO URBAN PLANNING – HARDWARE OF THE CITY 6/02/2018 ©VITO – Not for distribution 80 ENERGY EFFICIENCY RENEWABLE GENERATION STORAGE & FLEXIBILITY
  65. 65. 6/02/2018 ©VITO – Not for distribution 81 Hooyberghs, H., Verbeke, S., Lauwaet, D., Costa, H., Floater, G., & De Ridder, K. (2017). Influence of climate change on summer cooling costs and heat stress in urban office buildings. Climatic Change, 144(4), 721-735. ENERGY EFFICIENCY – THERMAL COMFORT – HEALTH the challenge in keeping Western-European office buildings comfortable until the end of the 21st century … large decreases in cooling costs (up to 30%) caused by the introduction of (external) shading and increased night-time ventilation in actively cooled buildings, and the improvements in working conditions in free-running buildings caused by moving workers to cooler locations and splitting workdays in morning and evening shifts.
  66. 66. 6/02/2018 ©VITO – Not for distribution 82 BUILT ENVIRONMENT – GREEN – URBAN CLIMATE
  67. 67. component building urban scale SMARTNESS TO SOLVE THIS OPTIMIZATION PUZZLE
  68. 68. Data processing and algorithms Sensors and devices Metering, monitoring devices and sensors Aerial and satellite data Buildings and infrastructures, real time and predictive climate data Application generated data User and usage related content, context and feedback data INCREASING POWER OF DATA
  69. 69. Leuven Climate Neutral 2030 THE SOFTWARE - CITYZEN CENTRED APPROACH
  70. 70. Ipsos, 2012 Environmentally friendly behaviour KnowledgeonEnergy THÉ ENERGY USER DOES NOT EXIST
  71. 71. © VITO EBECS home energy check Your Energy Plan DEBURDEN THE END USER FROM DECISION STRESS
  72. 72. 6/02/2018 ©VITO – Not for distribution 88 © VITO EBECS home energy check www.homefit.be NEW BUSINESS MODELS CUSTOMIZED SERVICES
  73. 73. 6/02/2018 ©VITO – Not for distribution 89 MOBILITY AS A SERVICE Mobility Comfort @ ¼ of annual cost SHARED, AUTONOMOUS, CLEAN MOBILITY
  74. 74. DRUK OP GEZONDHEIDSSYSTEMEN VERLICHTEN SUSTAINABLE HEALTH@VITO 6/02/2018 ©VITO – Not for distribution 90 Rudi Torfs
  75. 75. 6/02/2018 ©VITO – Not for distribution 91 Success of Healthcare is unsustainable
  76. 76. VITO icons can be found on: Y:_StoresStore02BeeldDataLogo's__VITOIconen VITO pictures can be found on: Y:_StoresStore02BeeldDataFoto Future healthcare will tackle disease by moving away from a ‘one size fits all approach’, by integrating data on the entire dynamic biological makeup of each individual, as well as the lifestyle and environmental factors that interact with this makeup to develop a complex and individual phenotype. This integrated information will be used to identify the most appropriate healthcare for individual citizens.
  77. 77. https://www.peekvision.org/ Understanding how environment, lifestyle and genotype influence health creates potential for improved preventative approaches integration OMICS
  78. 78. Non-invasive early diagnosis of disease for cost-efficient therapies www.iflexis.com © www.owlstonemedical.com
  79. 79. Empowerment & Participation The connected city offers citizens the opportunity to actively participate in policy and sustainability in cities by measuring their own living environment and regaining information that empowers them to ask for or seek solutions to protect their health 6/02/2018 ©VITO – Not for distribution 95
  80. 80. Quality and cost of sensors are improving – enabling more and personal measurements 6/02/2018 ©VITO – Not for distribution 9635$ © Plumelabs – source flow.plumelabs.com © Plumelabs – source flow.plumelabs.com 139$ ?
  81. 81. CO-PRODUCTION OF KNOWLEDGE DENCITY ONDERZOEK NAAR EEN FIJNMAZIG CITY-SENSING NETWERK VOOR OMGEVINGSPARAMETERS PARTNERS: IMEC, VMM, VITO DOEL: NETWERK VAN SENSOREN OPZETTEN DAT KWALITEITSVOLLE DATA GENEREERT 6/02/2018 ©VITO – Not for distribution 97
  82. 82. 6/02/2018 ©VITO – Not for distribution 98 The point of care @ Home: big opportunity for better integration of care in the smart & connected house THE IOT PROVIDES COMFORT, SECURITY, LEISURE… AND HEALTH? indoor air quality sensor box
  83. 83. Activ84Health: user centered design & solution to stay physically active 6/02/2018 ©VITO – Not for distribution 99
  84. 84. • INTEGRATED CARE REQUIRES COLLABORATION ACROSS SECTORS AND DATA… LOTS OF DATA 6/02/2018 ©VITO – Not for distribution 100
  85. 85. inclusiveness 6/02/2018 ©VITO – Not for distribution 101 Time is right and technologies are there to set up large population studies Systems biology, sensors, automatisation, mobile internet, cloud computing, AI/Machine learning, data analytics Just Do It https://www.nehi.net/writable/publication_files/file/paradox_full_report.pdf
  86. 86. No solution [to the problem of poverty] is so effective as providing income to the poor. Whether in the form of food, housing, health services, education or money, income is an excellent antidote for deprivation. John Kenneth Galbraith, The age of uncertainty, 1979 6/02/2018 ©VITO – Not for distribution 102
  87. 87. What we have now… • A system challenged by ( at least) 5 disruptive forces • The Greying patient ( and Provider…) • The Lifestyle Epidemic • The Information Revolution • The Blessing and Curse of Technology • The New Health Care Consumer ( and Provider…) A Rosen, Executive Research Brief, The Advisory Board, 2014
  88. 88. The Greying Patient 110
  89. 89. The Greying Provider 111
  90. 90. The Lifestyle Epidemic 112
  91. 91. The Lifestyle Epidemic 113
  92. 92. The Information Revolution 114
  93. 93. The Information Revolution 115
  94. 94. The Blessing and Curse of technology
  95. 95. The Blessing and Curse of Technology US approves first cancer drug to use patient's own cells – with $475,000 price tag 117
  96. 96. The New Healthcare Consumer 118
  97. 97. The New Healthcare Provider 119
  98. 98. What we can have…
  99. 99. ...but in a world with limited budgets... 122
  100. 100. ...where many needs have been met... 123 81,1 80,782,282,382,382,482,983,083,083,784,084,284,4 78,2 77,1 75,4 77,278,077,278,278,978,479,078,479,2 77,5 0 10 20 30 40 50 60 70 80 90 FR SWITZ* ITA* AUS CAN* SWE NOR* GER* NETH OECD Median NZ UK** US* Female Male
  101. 101. ...and spending yet more money is insane... 124
  102. 102. …where 1 out three dollars/euro’s/…spent is pure waste…
  103. 103. …where 50 % of the total budget is spent on 5% of the population…
  104. 104. …and where less than 5% is spent on prevention…?!
  105. 105. What we should have… • A system that saves and fosters Health • Collectively • Personally • Predictive • Preventive • And that supplies , when saving health fails, Care for the diseased,of the highest possible quality
  106. 106. What is “Quality of Care” ‘The degree to which health services for individuals and populations increase the likelihood of desired health outcomes and are consistent with current professional knowledge’ (IOM) = a worldwide challenge
  107. 107. What is “Quality of Care” ? “Quality” contains various elements • Effective • Efficient • Continuous • Safe • Patientcentered • Timely • Accessible • Integrated
  108. 108. What we should have… Bodenheimer & Sinsky, Ann Fam Med 2014;12:573-6
  109. 109. How to maximize value for patients in the HC system Volume-based Value-based Payment FFS Outcome based Incentive Volume Value Focus Acute episodes Populations Role of provider Single episodes Care continuum Information Retrospective Real-time & predicitve Leadership style Managerial divisional/departemental thinking Thinking across organisation
  110. 110. Belgian hospitalitis... International comparison shows – More acute hospital beds – Many more psychiatric hospital beds – More hospital admissions – Longer hospitalisation stays – More hospitalisation days / inhabitant – More medical equipment & usage offering ...than the average European country
  111. 111. Netwerking : the New Holy Grail..?
  112. 112. The Hospital of the Future is a Network •Published on February 17, 2017185 Jeroen Tas Chief Innovation & Strategy Officer at Philips Connecting Care for Continuous Hlth
  113. 113. Focus on CARE in horizontal networks Focus on specialisation in clinical networks
  114. 114. Hospital networks: quo vadis?
  115. 115. But: 145 Braithwaite et al: Complexity Science in Healthcare. Aspirations, approaches, applications and accomplishments. A White Paper. Australian Institute of Health Innovation.
  116. 116. Traditional Systems • Improvement by decomposing performance and management into component elements, and subsequently recomposing it by integrating the designed solution for each element • Characteristics: • Ability to de- and recompose the elements of the system; “designed” • Linearity, predictability, “dead” • Can be complicated, but not “complex” • Power with authority and resources to (re)design the system • Works well in automotive, manufacturing, retail,… CAS • Can NOT be addressed thru hierarchical de/recomposition! • Characteristics: • Non-linear & dynamic : system behaviour may appear to be random/chaotic • Composed by individual agents who’s behaviour is based on physical, psychological, or social rules rather than on demands of the system • Agents are often conflicting and intelligent : the overall system behaviour learns and adapts • Hence may lead to self- organisation : patterns emerge rather than being designed • No single point of control : no one is in charge
  117. 117. 147
  118. 118. 148
  119. 119. Real challenges… • Do we accept that “Healthcare” is ( or at least behaves like) a CAS (Complex Adaptive System ) with it’s own governing laws ? • And, therefore, is in need for a longterm purpose (“Ikigaï”) and framework design, and should allow for the role of non-linear thinking? E.g., allowing for Serendipity • If Integrated Care is that purpose, should the obvious first step not be...(re)integration..? • (Hence, “networking” is (only) a means, not a goal) • Do we accept than, that : “collaboration”, “networking”,… and therefore Healthcare, is foremost dependent on human interaction (sometimes two are sufficient…)
  120. 120. 150 Build serendipity into your strategy process
  121. 121. 6/02/2018 Marc Noppen Vlerick Strategy© 151
  122. 122. …so we should never,never forget the Purpose, The Human Factor…
  123. 123. Healthcare 2.0 Marc Noppen,MD,PhD CEO, University Hospital UZ Brussel marc.noppen@uzbrussel.be

×